Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia

L Maahs, A Tang, ZA Saheli, B Jacob… - Journal of Oncology …, 2022 - journals.sagepub.com
Introduction Granulocyte colony-stimulating factors are used in medical oncology for the
prevention of neutropenia. On-body injectors (OBI) have an advantage over the traditional …

[PDF][PDF] Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia

LG Maahs, A Tang, Z Al-Saheli, B Jacob, R Polasani - scholarlycommons.henryford.com
Introduction: Granulocyte colony-stimulating factors are used in medical oncology for the
prevention of neutropenia. On-body injectors (OBI) have an advantage over the traditional …

Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia.

L Maahs, A Tang, ZA Saheli, B Jacob… - Journal of Oncology …, 2020 - europepmc.org
Methods Women with breast cancer diagnosed between June 2015 and June 2016 treated
with cytotoxic chemotherapy and a granulocyte colony-stimulating factor were …

Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia

L Maahs, A Tang, Z Al Saheli… - … publication of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Granulocyte colony-stimulating factors are used in medical oncology for the
prevention of neutropenia. On-body injectors (OBI) have an advantage over the traditional …

Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia.

L Maahs, A Tang, ZA Saheli, B Jacob… - Journal of Oncology …, 2022 - search.ebscohost.com
Introduction: Granulocyte colony-stimulating factors are used in medical oncology for the
prevention of neutropenia. On-body injectors (OBI) have an advantage over the traditional …

Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia

LG Maahs, A Tang, Z Al-Saheli… - J Oncol …, 2020 - scholarlycommons.henryford.com
INTRODUCTION: Granulocyte colony-stimulating factors are used in medical oncology for
the prevention of neutropenia. On-body injectors (OBI) have an advantage over the …